These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24376273)

  • 1. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.
    Rolling T; Agbenyega T; Issifou S; Adegnika AA; Sylverken J; Spahlinger D; Ansong D; Löhr SJ; Burchard GD; May J; Mordmüller B; Krishna S; Kremsner PG; Cramer JP
    J Infect Dis; 2014 Jun; 209(12):1921-8. PubMed ID: 24376273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed haemolysis after artesunate treatment of severe malaria - review of the literature and perspective.
    Rolling T; Agbenyega T; Krishna S; Kremsner PG; Cramer JP
    Travel Med Infect Dis; 2015; 13(2):143-9. PubMed ID: 25812775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.
    Jauréguiberry S; Thellier M; Ndour PA; Ader F; Roussel C; Sonneville R; Mayaux J; Matheron S; Angoulvant A; Wyplosz B; Rapp C; Pistone T; Lebrun-Vignes B; Kendjo E; Danis M; Houzé S; Bricaire F; Mazier D; Buffet P; Caumes E;
    Emerg Infect Dis; 2015 May; 21(5):804-12. PubMed ID: 25898007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial.
    Kremsner PG; Adegnika AA; Hounkpatin AB; Zinsou JF; Taylor TE; Chimalizeni Y; Liomba A; Kombila M; Bouyou-Akotet MK; Mawili Mboumba DP; Agbenyega T; Ansong D; Sylverken J; Ogutu BR; Otieno GA; Wangwe A; Bojang KA; Okomo U; Sanya-Isijola F; Newton CR; Njuguna P; Kazungu M; Kerb R; Geditz M; Schwab M; Velavan TP; Nguetse C; Köhler C; Issifou S; Bolte S; Engleitner T; Mordmüller B; Krishna S
    PLoS Med; 2016 Jan; 13(1):e1001938. PubMed ID: 26757276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
    Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.
    Charles M; Patterson JM; Asadi L; Houston S
    Am J Trop Med Hyg; 2015 Oct; 93(4):819-21. PubMed ID: 26240154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
    Karunajeewa HA; Reeder J; Lorry K; Dabod E; Hamzah J; Page-Sharp M; Chiswell GM; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):968-74. PubMed ID: 16495259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda.
    Gasasira AF; Kamya MR; Achan J; Mebrahtu T; Kalyango JN; Ruel T; Charlebois E; Staedke SG; Kekitiinwa A; Rosenthal PJ; Havlir D; Dorsey G
    Clin Infect Dis; 2008 Apr; 46(7):985-91. PubMed ID: 18444813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-day nonobserved artesunate monotherapy for treating uncomplicated Falciparum malaria in young Gabonese children.
    Schwarz NG; Oyakhirome S; Pötschke M; Gläser B; Klein Klouwenberg P; Altun H; Adegnika AA; Issifou S; Kun JF; Kremsner PG; Grobusch MP
    Am J Trop Med Hyg; 2005 Oct; 73(4):705-9. PubMed ID: 16222013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial.
    Sykes A; Hendriksen I; Mtove G; Mandea V; Mrema H; Rutta B; Mapunda E; Manjurano A; Amos B; Reyburn H; Whitty CJ
    Clin Infect Dis; 2009 Oct; 49(8):1195-201. PubMed ID: 19769536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
    Tiono AB; Dicko A; Ndububa DA; Agbenyega T; Pitmang S; Awobusuyi J; Pamba A; Duparc S; Goh LE; Harrell E; Carter N; Ward SA; Greenwood B; Winstanley PA
    Am J Trop Med Hyg; 2009 Dec; 81(6):969-78. PubMed ID: 19996424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of post-malarial anemia in African children treated with parenteral artesunate.
    Scheu K; Adegnika AA; Addo MM; Ansong D; Cramer JP; Fürst S; Kremsner PG; Kurth F; Jacobs T; May J; Ramharter M; Sylverken J; Vinnemeier CD; Agbenyega T; Rolling T
    Sci Rep; 2019 Dec; 9(1):18134. PubMed ID: 31792345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed haemolysis secondary to treatment of severe malaria with intravenous artesunate: Report on the experience of a referral centre for tropical infections in Spain.
    Aldámiz-Echevarría Lois T; López-Polín A; Norman FF; Monge-Maillo B; López-Vélez R; Perez-Molina JA
    Travel Med Infect Dis; 2017; 15():52-56. PubMed ID: 27818359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.
    Karunajeewa HA; Kemiki A; Alpers MP; Lorry K; Batty KT; Ilett KF; Davis TM
    Pediatr Infect Dis J; 2003 Mar; 22(3):251-6. PubMed ID: 12634587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed haemolysis after treatment with intravenous artesunate in patients with severe malaria in India.
    Savargaonkar D; Das MK; Verma A; Mitra JK; Yadav CP; Srivastava B; Anvikar AR; Valecha N
    Malar J; 2020 Jan; 19(1):39. PubMed ID: 31969146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on cases of delayed hemolysis after parenteral artesunate therapy for malaria - United States, 2008 and 2013.
    Paczkowski MM; Landman KL; Arguin PM;
    MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(34):753-5. PubMed ID: 25166926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
    Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous artesunate for the treatment of severe malaria.
    Hess KM; Goad JA; Arguin PM
    Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
    Noubiap JJ
    J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.